BIOCRYST PHARMACEUTICALS INC - FORM 10-Q - EX-32.1 - CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 - SECTION 906 - November 3, 2011

Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - BIOCRYST PHARMACEUTICALS INCFinancial_Report.xls
10-Q - FORM 10-Q - BIOCRYST PHARMACEUTICALS INCd249127d10q.htm
EX-31.1 - CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 - BIOCRYST PHARMACEUTICALS INCd249127dex311.htm
EX-32.2 - CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 - SECTION 906 - BIOCRYST PHARMACEUTICALS INCd249127dex322.htm
EX-31.2 - CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 - BIOCRYST PHARMACEUTICALS INCd249127dex312.htm

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of BioCryst Pharmaceuticals, Inc. (the “Company”) on Form 10-Q for the period ending September 30, 2011 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jon P. Stonehouse, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

 

  (1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

/s/ Jon P. Stonehouse

Jon P. Stonehouse

President and Chief Executive Officer

Date: November 3, 2011

BIOCRYST PHARMACEUTICALS INC Reports